Xcout Intel
Myosana Therapeutics Inc.
Myosana Therapeutics, Inc. is a biotechnology research company based in Seattle, Washington, pioneering non-viral gene therapy treatments for muscle diseases.
Subscribe to see Myosana Therapeutics Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Myosana Therapeutics Inc. at a glance
Myosana Therapeutics Inc. is a biotechnology company headquartered in United States. It has raised at least $11.4M across the 2 funding rounds on record. Its most recent funding round, Seed, raised $5M in January 2023. Xcout tracks 2 named people at Myosana Therapeutics Inc., including Stan Froehner (CFO, Chairman, and Co-Founder).
Myosana Therapeutics Inc. leadership
- Stan FroehnerCFO, Chairman, and Co-Founder
- Nick WhiteheadCEO, CSO & Co-Founder
Myosana Therapeutics Inc. funding rounds
At least $11.4M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $5M | 5 named | |
| SEC Form D filing | $6.4M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Myosana Therapeutics Inc. competitors
A few of Myosana Therapeutics Inc.'s closest competitors — see the full list of competitors and alternatives →
Dyne Therapeutics, Inc. is a U.S.-based biotechnology firm focused on developing advanced treatments for genetically driven muscle disorders. Utilizing its proprietary FORCE platform, which is engineered to deliver disease-modifying therapeutics, the company is actively engaged in various programs. These initiatives target conditions such as myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral dystrophy, in addition to other rare skeletal, cardiac, and metabolic muscle diseases. The company was founded in 2017 and maintains its corporate headquarters in Waltham, Massachusetts.
Shape Therapeutics, Inc. is a biotechnology research company founded in 2018 and headquartered in Seattle, Washington. The firm focuses on advancing the future of medicine through programmable RNA technologies and therapeutics.
NanoVation Therapeutics is a platform developer headquartered in Vancouver, British Columbia, that partners with leading pharmaceutical and biotech companies to enable genetic medicines.
Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing small-molecule treatments for a range of musculoskeletal disorders. Its leading investigational drug, EDG-5506, is an orally administered compound specifically engineered to tackle the fundamental genetic causes of dystrophinopathies, including Duchenne and Becker muscular dystrophy. This candidate has successfully concluded its Phase 1 clinical trial. Beyond EDG-5506, Edgewise maintains a pipeline of precision medicine candidates designed to modulate key muscle proteins, thereby addressing various genetically defined muscle conditions. Established in 2017, the company is headquartered in Boulder, Colorado.
Atsena Therapeutics, Inc. is a clinical-stage gene therapy company headquartered in Durham, North Carolina, established in 2019. The firm focuses on developing novel gene therapies to treat debilitating inherited blinding diseases using proprietary vector delivery technologies. Its scientific pipeline aims to address areas of high unmet medical need in ophthalmology.
Averna Therapeutics is a biotechnology company developing genomic medicines utilizing RNA and lipid nanoparticle technologies. The company focuses on safe and efficient gene insertion and the treatment of rare genetic diseases through research and development teams located in Boston and Israel.
Get Myosana Therapeutics Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Myosana Therapeutics Inc. in Xcout Intel
- 2 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access